Data / Form D filings / Auxilium Biotechnologies Inc.
Auxilium Biotechnologies Inc.: Form D filings
Auxilium Biotechnologies Inc., a biotechnology company in San Diego, CA, filed 3 Form D notices with the SEC between 2020 and 2025. The latest, on December 11, 2025, reports $3.9 million sold of a $10 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3945 CARMEL SPRINGS WAY, San Diego, CA, 92130
- Phone
- (858) 699-9443
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1800618
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Amendment | $10,000,000 | $3,936,015 | $6,063,985 | 16 | Sep 18, 2025 | sec.gov |
| Oct 23, 2025 | New notice | $10,000,000 | $3,536,015 | $6,463,985 | 14 | Sep 18, 2025 | sec.gov |
| Jan 21, 2020 | New notice | $3,999,999 | $3,249,988 | $750,011 | 18 | Jan 10, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yacov Koffler | Executive Officer, Director | |
| Craig Andrews | Director | |
| Mark Tuszynski | Director | |
| Robert Engler | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Dec 8, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Auxilium Biotechnologies Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.